These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25274272)

  • 1. The carboxyl terminus of VEGF-A is a potential target for anti-angiogenic therapy.
    Carter JG; Gammons MV; Damodaran G; Churchill AJ; Harper SJ; Bates DO
    Angiogenesis; 2015 Jan; 18(1):23-30. PubMed ID: 25274272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
    Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
    Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastrong trapping of VEGF by graphene oxide: Anti-angiogenesis application.
    Lai PX; Chen CW; Wei SC; Lin TY; Jian HJ; Lai IP; Mao JY; Hsu PH; Lin HJ; Tzou WS; Chen SY; Harroun SG; Lai JY; Huang CC
    Biomaterials; 2016 Dec; 109():12-22. PubMed ID: 27639528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
    Forooghian F; Das B
    Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF111b, a new member of VEGFxxxb isoforms and induced by mitomycin C, inhibits angiogenesis.
    Gu F; Li X; Kong J; Pan B; Sun M; Zheng L; Yao Y
    Biochem Biophys Res Commun; 2013 Nov; 441(1):18-24. PubMed ID: 24125722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-angiogenic isoforms of VEGF in health and disease.
    Qiu Y; Hoareau-Aveilla C; Oltean S; Harper SJ; Bates DO
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1207-13. PubMed ID: 19909248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells.
    Chuang CH; Liu CH; Lu TJ; Hu ML
    Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor.
    Perrin RM; Konopatskaya O; Qiu Y; Harper S; Bates DO; Churchill AJ
    Diabetologia; 2005 Nov; 48(11):2422-7. PubMed ID: 16193288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Characterization of Abicipar-Pegol, an Anti-VEGF DARPin Therapeutic That Potently Inhibits Angiogenesis and Vascular Permeability.
    Rodrigues GA; Mason M; Christie LA; Hansen C; Hernandez LM; Burke J; Luhrs KA; Hohman TC
    Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5836-5846. PubMed ID: 30535424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent anti-angiogenesis and anti-tumor activity of a novel human anti-VEGF antibody, MIL60.
    Yang J; Wang Q; Qiao C; Lin Z; Li X; Huang Y; Zhou T; Li Y; Shen B; Lv M; Feng J
    Cell Mol Immunol; 2014 May; 11(3):285-93. PubMed ID: 24608894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capacity of aflibercept to counteract VEGF-stimulated abnormal behavior of retinal microvascular endothelial cells.
    Deissler HL; Lang GK; Lang GE
    Exp Eye Res; 2014 May; 122():20-31. PubMed ID: 24631334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two natural eudesmane-type sesquiterpenes from Laggera alata inhibit angiogenesis and suppress breast cancer cell migration through VEGF- and Angiopoietin 2-mediated signaling pathways.
    Liang N; Li Y; Chung HY
    Int J Oncol; 2017 Jul; 51(1):213-222. PubMed ID: 28534941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology study of a chimeric decoy receptor trap fusion protein on retina neovascularization by dual blockage of VEGF and FGF-2.
    Jiang J; Xu K; Wang L; Xin W; Zhao G; Huang M; Li S; Luan X; Fang J
    Eur J Pharm Sci; 2018 Aug; 121():251-259. PubMed ID: 29715501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-angiogenic activity and mechanism of kaurane diterpenoids from Wedelia chinensis.
    Huang W; Liang Y; Wang J; Li G; Wang G; Li Y; Chung HY
    Phytomedicine; 2016 Mar; 23(3):283-92. PubMed ID: 26969382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A natural anti-inflammatory enone fatty acid inhibits angiogenesis by attenuating nuclear factor-κB signaling in vascular endothelial cells.
    Furuno A; Watari K; Nakamura M; Fukunaga Y; Jung JH; Ono M
    Int J Oncol; 2011 Feb; 38(2):493-501. PubMed ID: 21132269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting angiogenesis with human single-chain variable fragment antibody targeting VEGF.
    Hosseini H; Rajabibazl M; Ebrahimizadeh W; Dehbidi GR
    Microvasc Res; 2015 Jan; 97():13-8. PubMed ID: 25250517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
    Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K
    Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor-A
    Ved N; Hulse RP; Bestall SM; Donaldson LF; Bainbridge JW; Bates DO
    Clin Sci (Lond); 2017 Jun; 131(12):1225-1243. PubMed ID: 28341661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy.
    Sulaiman RS; Merrigan S; Quigley J; Qi X; Lee B; Boulton ME; Kennedy B; Seo SY; Corson TW
    Sci Rep; 2016 May; 6():25509. PubMed ID: 27148944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balance of pro- versus anti-angiogenic splice isoforms of vascular endothelial growth factor as a regulator of neuroblastoma growth.
    Peiris-Pagès M; Harper SJ; Bates DO; Ramani P
    J Pathol; 2010 Oct; 222(2):138-47. PubMed ID: 20662003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.